DRIEHAUS CAPITAL MANAGEMENT LLC
Q2 2022 13F-HR Holdings
Net value change ($000)
-1,970,372
(-24.2%)
New positions
91
Sold out positions
117
Turnover %
40.4%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| FCN | 59,519 | NEW |
| MGPI | 33,092 | 148.7% |
| XENE | 32,681 | 32.4% |
| AMX | 30,830 | NEW |
| XPEV | 30,642 | NEW |
| RLI | 26,151 | NEW |
| GO | 25,856 | NEW |
| Global Blood Therapeutics, Inc. | 25,747 | NEW |
| GTLB | 25,662 | NEW |
| TENB | 25,233 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| INFY | -85,794 | -100.0% |
| TSM | -84,498 | -21.4% |
| SpringWorks Therapeutics, Inc. | -75,248 | -72.4% |
| RLAY | -69,434 | -57.3% |
| ACLS | -67,498 | -74.6% |
| PRKS | -64,191 | -100.0% |
| VALE | -56,189 | -100.0% |
| TFIN | -53,004 | -82.3% |
| IBN | -49,546 | -41.5% |
| Spirit AeroSystems Holdings, Inc. | -46,032 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
158
(0.0% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|